Daniel S. Peeper

27.3k citations

115 papers · 14.1k indexed · 6 hit papers · h-index 47

Aging top 0.5%
Cancer Research top 0.5%
Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers 15
- Cancer-related Molecular Pathways 13
- Cancer Cells and Metastasis 11
- Cutaneous Melanoma Detection and Management 10
- CAR-T cell therapy research 9
Physiology top 0.5%
- Telomeres, Telomerase, and Senescence 20
Molecular Biology top 0.5%
- Melanoma and MAPK Pathways 30
- Ubiquitin and proteasome pathways 10

Co-authors: Thomas Kuilman Chrysiis Michaloglou Wolter J. Mooi Liesbeth C.W. Vredeveld Benjamin D. Rowland Sirith Douma Thomas R. Geiger René Bernards
Cited by: Aging Cancer Research Oncology
Journals: Cancer Research (7 papers)Pigment Cell & Melanoma Research (6 papers)Genes & Development (5 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Daniel S. Peeper

110 papers receiving 13.9k citations

Hit Papers

6 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2014 Nature Communications
2013 Nature
2010 Genes & Development
2009 Nature reviews. Cancer
2008 Cell
2005 Nature

Peers

Countries citing papers authored by Daniel S. Peeper

Since Specialization

Citations

This map shows the geographic impact of Daniel S. Peeper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel S. Peeper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel S. Peeper more than expected).

Fields of papers citing papers by Daniel S. Peeper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel S. Peeper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel S. Peeper. The network helps show where Daniel S. Peeper may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Daniel S. Peeper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel S. Peeper Line = papers co-authored together Daniel S. Peeper links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	TRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptors Cell Death and Disease ·Jennifer K. Wagner,David W. Vredevoogd,Xin Yu,Dong Lu,Daniel S. Peeper,Heike M. Hermanns,Jin Wang,Harald Wajant,Daniela Siegmund	2025	5
2	Chemotherapeutic agents and leucine deprivation induce codon-biased aberrant protein production in cancer Nucleic Acids Research ·Baiq Santi Sulistiorini,Remco Nagel,Planelles Lillo,Onno B. Bleijerveld,M Kamandlou,Mittal Rajinder,H. Fühner,Natalie Proost,Marieke van de Ven,David Smrčka,Т.Л. Паникоровский,Abhijeet Pataskar,Daniel S. Peeper,Julien Champagne,Reuven Agami	2024	2
3	The Elongin BC Complex Negatively Regulates AXL and Marks a Differentiated Phenotype in Melanoma Molecular Cancer Research ·D. V. Shtansky,Joleen J.H. Traets,door W.R,Andrea P. Torres‐Flores,Ji‐Ying Song,Scott I Berman,Thomas Kuilman,Daniel S. Peeper	2023	4
4	1121P Interferon-gamma (IFNy) gene signature as a predictive biomarker for response in lactate dehydrogenase (LDH) low advanced melanoma patients Annals of Oncology ·Lianne Hoeijmakers,Petros Dimitriadis,Rosie Smith,Judith M. Versluis,Daniel S. Peeper,Christian U. Blank	2023	0
5	Acidity‐mediated induction of FoxP3 ⁺ regulatory T cells European Journal of Immunology ·Disha Rao,Feng Qiao Wang,Ruben Lacroix,Petros Dimitriadis,Joanna Kaplon,K.R. Weisbrod,Luciana Ballester de Mello Godoy,Esmée P. Hoefsmit,Kathrin Renner,Christian U. Blank,Daniel S. Peeper	2023	17
6	Inhibitor of Apoptosis Proteins Antagonist Induces T-cell Proliferation after Cross-Presentation by Dendritic Cells Cancer Immunology Research ·Esmée P. Hoefsmit,Luciana Ballester de Mello Godoy,Disha Rao,Shakhawan Abdullah Sabr,Petros Dimitriadis,Cor Lieftink,Ben Morris,Elisa A. Rozeman,Irene L. M. Reijers,Ruben Lacroix,Y Lu,Maarten A. Ligtenberg,Roderick L. Beijersbergen,Daniel S. Peeper,Christian U. Blank	2023	10
7	RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells Cell Reports Medicine ·Zhengkui Zhang,Xiangjun Kong,Maarten A. Ligtenberg,Eugeniy Butkov,Nils L. Visser,Beaunelle de Bruijn,Kelly E. Stecker,O Horn,Thomas Kuilman,Esmée P. Hoefsmit,David W. Vredevoogd,Georgi Apriamashvili,Monica Chande,Emile E. Voest,Sjoerd Klarenbeek,Maarten Altelaar,Daniel S. Peeper	2022	30
8	Predictive Immune-Checkpoint Blockade Classifiers Identify Tumors Responding to Inhibition of PD-1 and/or CTLA-4 Clinical Cancer Research ·Oscar Krijgsman,Kristel Kemper,Julia Boshuizen,David W. Vredevoogd,Elisa A. Rozeman,白沢郁郎,Beaunelle de Bruijn,Paulien Cornelissen‐Steijger,Aida Shahrabi,Martin Del Castillo Velasco‐Herrera,Ji‐Ying Song,Maarten A. Ligtenberg,Wei Wang,Thomas Kuilman,Petra Ross‐Macdonald,John B.A.G. Haanen,David J. Adams,Christian U. Blank,Daniel S. Peeper	2021	3
9	Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody–Drug Conjugate and Immune Checkpoint Blockade Cancer Research ·Julia Boshuizen,Nora Pencheva,Oscar Krijgsman,Unikovski Aharon,Patricia Garrido Castro,Beaunelle de Bruijn,Maarten A. Ligtenberg,Zhouqing Dai,David W. Vredevoogd,Ji‐Ying Song,Nils L. Visser,Georgi Apriamashvili,Maarten L. Janmaat,Theo S. Plantinga,Patrick Franken,Mischa Houtkamp,Andreas Lingnau,Maria Jure‐Kunkel,Daniel S. Peeper	2021	48
10	Reversal of pre-existing NGFR-driven tumor and immune therapy resistance Nature Communications ·Julia Boshuizen,David W. Vredevoogd,Oscar Krijgsman,Maarten A. Ligtenberg,조유회,Beaunelle de Bruijn,Dennie T. Frederick,Juliana C.N. Kenski,Mara Parren,功大川,Max F. Madu,Elisa A. Rozeman,Ji‐Ying Song,Hugo M. Horlings,Christian U. Blank,Alexander C. J. van Akkooi,Keith T. Flaherty,Genevieve M. Boland,Daniel S. Peeper	2020	66
11	In Vivo ERK1/2 Reporter Predictively Models Response and Resistance to Combined BRAF and MEK Inhibitors in Melanoma Molecular Cancer Therapeutics ·Ileine M. Sanchez,Timothy J. Purwin,Inna Chervoneva,Dan A. Erkes,Mai Q. Nguyen,Michael A. Davies,Katherine L. Nathanson,Kristel Kemper,Daniel S. Peeper,Andrew E. Aplin	2019	16
12	Systematic functional perturbations uncover a prognostic genetic network driving human breast cancer Oncotarget ·Tristan Gallenne,Kenneth N. Ross,Nils L. Visser,Ziyan Zhang,Christophe Desmet,Ben S. Wittner,Lodewyk F.A. Wessels,Sridhar Ramaswamy,Daniel S. Peeper	2017	30
13	Massive reshaping of genome–nuclear lamina interactions during oncogene-induced senescence Genome Research ·Christelle Lenain,Carolyn A. de Graaf,Ludo Pagie,Nils L. Visser,Marcel de Haas,Sandra S. de Vries,Daniel Peric‐Hupkes,Bas van Steensel,Daniel S. Peeper	2017	65
14	Intra‐ and inter‐tumor heterogeneity in a vemurafenib‐resistant melanoma patient and derived xenografts EMBO Molecular Medicine ·Kristel Kemper,Oscar Krijgsman,Paulien Cornelissen‐Steijger,Aida Shahrabi,Fleur Weeber,Ji‐Ying Song,Thomas Kuilman,Daniël J. Vis,Lodewyk F.A. Wessels,Emile E. Voest,Ton N. Schumacher,Christian U. Blank,David J. Adams,John B.A.G. Haanen,Daniel S. Peeper	2015	103
15	Near‐genomewide RNA i screening for regulators of BRAF ^V ^600E ‐induced senescence identifies RASEF , a gene epigenetically silenced in melanoma Pigment Cell & Melanoma Research ·Joanna Kaplon,Hömig-Hölzel Cornelia,尚子長地,Katrin Meissl,Els M.E. Verdegaal,Sjoerd H. van der Burg,Remco van Doorn,Daniel S. Peeper	2014	13
16	Genome‐wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma Pigment Cell & Melanoma Research ·尚子長地,Marjon A. Smit,Joost J. van den Oord,Jelle J. Goeman,Els M.E. Verdegaal,Sjoerd H. van der Burg,Marguerite Stas,Samuel J. Beck,Nelleke A. Gruis,Cornelis P. Tensen,Rein Willemze,Daniel S. Peeper,Remco van Doorn	2013	49
17	Functional identification of LRF as an oncogene that bypasses RAS V12 -induced senescence via upregulation of CYCLIN E Carcinogenesis ·Liesbeth C.W. Vredeveld,Benjamin D. Rowland,Sirith Douma,René Bernards,Daniel S. Peeper	2009	16
18	Senescence-messaging secretome: SMS-ing cellular stressbreakdown → Nature reviews. Cancer ·Thomas Kuilman,Daniel S. Peeper	2009	700
19	Oncogene-Induced Cell Senescence — Halting on the Road to Cancer New England Journal of Medicine ·W. J. Mooi,Daniel S. Peeper	2006	280
20	The G1/S cell-cycle checkpoint in eukaryotic cells Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Daniel S. Peeper	1994	36

About Daniel S. Peeper

Daniel S. Peeper is a scholar working on Oncology, Molecular Biology and Cancer Research, having authored 115 papers that have together received 14.1k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (30 papers), Telomeres, Telomerase, and Senescence (20 papers), Cancer Immunotherapy and Biomarkers (15 papers), Cancer-related Molecular Pathways (13 papers), Cancer Cells and Metastasis (11 papers), Ubiquitin and proteasome pathways (10 papers), Cutaneous Melanoma Detection and Management (10 papers) and CAR-T cell therapy research (9 papers). The work is most often cited by research in Aging (436 citations), Cancer Research (2.6k citations) and Oncology (4.6k citations). Daniel S. Peeper has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Thomas Kuilman, Chrysiis Michaloglou, Wolter J. Mooi, Liesbeth C.W. Vredeveld, Benjamin D. Rowland, Sirith Douma, Thomas R. Geiger, René Bernards, Christophe Desmet and W. J. Mooi. Their work appears in journals such as Cancer Research, Pigment Cell & Melanoma Research, Genes & Development, Nature and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact